GastroCE
LECTURECME

Best of IBD Forum

Author(s)/Faculty: Stephen B. Hanauer, MD; William J. Sandborn, MD; Gary R. Lichtenstein, MD
Release Date: 11/27/2017Expiration Date: 11/26/2018
Credit Type: CMENumber of Credits: 1.5
Content Type: LectureProvider: Vindico Medical Education
Inflammatory bowel disease (IBD) is a chronic, frequently progressive condition that affects approximately 1 to 1.3 million people in the United States. Substantial room for improvement in the care of patients with IBD is needed, as evidenced by a recent study of insurance claims that showed approximately 80% of 32,883 patients with IBD received suboptimal therapy. The outcomes of patients with IBD are diminished by multiple factors, including uncertainty about approaches to diagnosis, assessment, and treatment, as well as a lack of knowledge about available therapies.